In October 2020, Senseonics asked the FDA to approve the 180-day wear model, however it’s still TBD on getting approval. It’s based mostly on the Omnipod DASH platform launched in 2019 and uses the identical insulin pods and mobile app. It will first be available to attach with the Dexcom CGM and later with Abbott’s FreeStyle Libre. Like Tandem’s Control-IQ, Horizon is a closed loop system, aka Artificial Pancreas technology. It connects the Omnipod tubeless patch pump to a CGM by way of a smart algorithm, permitting for computerized insulin dosing changes.
Distance studying amongst individuals is aided by video …